Income Statement Guard Therapeutics International AB

Equities

GUARD

SE0021181559

Biotechnology & Medical Research

Delayed Nasdaq Stockholm Other stock markets 17:00:00 10/09/2024 BST			5-day change	1st Jan Change
29.00 ^SEK	+2.11%		+0.69%	-18.99%

08-29	First Patient Dosed in Guard Therapeutics' Phase 2B Study POINTER	CI
08-27	Guard Therapeutics Plans New SEK80 Million Rights Issue to Fund Kidney Drug Study	MT

c567ac19f6e009e977b5def53391985.Xo7s-0R-7kexx_y7r0Q0VpT3oTxzHwFlw0dSNngG3v4.PfrfkSgcizXh9sjy2h5rGt2E83c9SHZWp3UBRTJtkrUu-KCLPUiMCuuQmw

Published financial data: GUARD THERAPEUTICS INTERNATIONAL AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	-	-	-	-	-
Total Revenues	-	-	-	-	-
Gross Profit	-	-	-	-	-
Selling General & Admin Expenses, Total	6.72M	5M	5.96M	8.82M	9.15M
R&D Expenses	37.56M	35.42M	75.33M	105M	106M
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	-	-143K	-	-	-
Other Operating Expenses, Total	44.28M	40.28M	81.28M	114M	115M
Operating Income	-44.28M	-40.28M	-81.28M	-114M	-115M
Interest Expense, Total	-872K	-7K	-1K	-1K	-5K
Interest And Investment Income	-	-	20K	138K	2.2M
Net Interest Expenses	-872K	-7K	19K	137K	2.19M
Currency Exchange Gains (Loss)	-	-	-765K	652K	-594K
Other Non Operating Income (Expenses)	-	-1K	-1K	1K	1K
EBT, Excl. Unusual Items	-45.16M	-40.28M	-82.03M	-113M	-113M
EBT, Incl. Unusual Items	-45.16M	-40.28M	-82.03M	-113M	-113M
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-45.16M	-40.28M	-82.03M	-113M	-113M
Net Income to Company	-45.16M	-40.28M	-82.03M	-113M	-113M
Net Income - (IS)	-45.16M	-40.28M	-82.03M	-113M	-113M
Net Income to Common Incl Extra Items	-45.16M	-40.28M	-82.03M	-113M	-113M
Net Income to Common Excl. Extra Items	-45.16M	-40.28M	-82.03M	-113M	-113M
Per Share Items
Net EPS - Basic	-22.24	-12.15	-18.39	-16.01	-11.26
Basic EPS - Continuing Operations	-22.24	-12.15	-18.39	-16.01	-11.26
Basic Weighted Average Shares Outstanding	2.03M	3.32M	4.46M	7.05M	10.06M
Net EPS - Diluted	-22.24	-12.15	-18.39	-16.01	-11.26
Diluted EPS - Continuing Operations	-22.24	-12.15	-18.39	-16.01	-11.26
Diluted Weighted Average Shares Outstanding	2.03M	3.32M	4.46M	7.05M	10.06M
Normalized Basic EPS	-13.9	-7.59	-11.49	-10.01	-7.04
Normalized Diluted EPS	-13.9	-7.59	-11.49	-10.01	-7.04
Supplemental Items
EBITDA	-43.29M	-40.12M	-81.27M	-114M	-115M
EBITA	-43.58M	-40.28M	-81.28M	-114M	-115M
EBIT	-44.28M	-40.28M	-81.28M	-114M	-115M
EBITDAR	-43.27M	-	-	-	-
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-28.22M	-25.18M	-51.27M	-70.52M	-70.83M
Interest on Long-Term Debt	16K	-	-	-	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	3.32M	1.92M	2.26M	3.84M	3.77M
General and Administrative Expenses	3.41M	3.08M	3.7M	4.97M	5.38M
Research And Development Expense From Footnotes	37.56M	35.42M	75.33M	105M	106M
Net Rental Expense, Total	22K	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	552K	617K	3.27M
Total Stock-Based Compensation	-	-	552K	617K	3.27M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	53.97M	90.04M	189M	201M	83.74M
Total Cash And Short Term Investments	53.97M	90.04M	189M	201M	83.74M
Accounts Receivable, Total	-	-	-	-	-
Other Receivables	1.38M	709K	931K	897K	667K
Total Receivables	1.38M	709K	931K	897K	667K
Prepaid Expenses	526K	427K	872K	685K	819K
Other Current Assets, Total	-1K	-	-	1K	-
Total Current Assets	55.87M	91.18M	190M	203M	85.23M
Gross Property Plant And Equipment	2.65M	2.02M	2.02M	2.02M	-
Accumulated Depreciation	-2.14M	-1.98M	-1.99M	-2.01M	-
Net Property Plant And Equipment	516K	44K	29K	15K	-
Other Intangibles, Total	7.32M	-	-	-	-
Deferred Charges Long-Term	0	-	-	-	-
Other Long-Term Assets, Total	-	-	-	-1K	-
Total Assets	63.71M	91.22M	190M	203M	85.23M
Liabilities
Accounts Payable, Total	2.52M	2.98M	6.29M	11.22M	5.49M
Accrued Expenses, Total	2.42M	3.1M	3.92M	10.79M	10.56M
Current Portion of Leases	176K	-	-	-	-
Current Income Taxes Payable	-	222K	270K	392K	268K
Other Current Liabilities	178K	201K	466K	290K	294K
Total Current Liabilities	5.3M	6.5M	10.94M	22.7M	16.61M
Long-Term Leases	15K	-	-	-	-
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	5.78M	5.03M	3.72M	2.55M	1.88M
Total Liabilities	11.09M	11.54M	14.66M	25.24M	18.49M
Common Stock, Total	52.36M	4.26M	6.86M	10.06M	10.06M
Additional Paid In Capital	45.42M	443M	619M	730M	733M
Retained Earnings	-45.16M	-368M	-450M	-563M	-676M
Comprehensive Income and Other	-	-	-1K	-1K	-1K
Total Common Equity	52.62M	79.69M	176M	177M	66.73M
Total Equity	52.62M	79.69M	176M	177M	66.73M
Total Liabilities And Equity	63.71M	91.22M	190M	203M	85.23M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.08M	4.26M	6.86M	10.06M	10.06M
ECS Total Common Shares Outstanding	3.08M	4.26M	6.86M	10.06M	10.06M
Book Value / Share	17.07	18.71	25.62	17.63	6.63
Tangible Book Value	45.3M	79.69M	176M	177M	66.73M
Tangible Book Value Per Share	14.7	18.71	25.62	17.63	6.63
Total Debt	191K	0	0	0	0
Net Debt	-53.78M	-90.04M	-189M	-201M	-83.74M
Debt Equivalent Oper. Leases	176K	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	2.05M	2.02M	2.02M	2.02M	-
Full Time Employees	-	7	10	12	11

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-45.16M	-40.28M	-82.03M	-113M	-113M
Depreciation & Amortization - CF	579K	161K	15K	15K	15K
Amortization of Goodwill and Intangible Assets - (CF)	703K	-	-	-	-
Depreciation & Amortization, Total	1.28M	161K	15K	15K	15K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	3.1M	-	-	-	-
Other Operating Activities, Total	250K	-2K	653K	-1.29M	3.07M
Change In Accounts Receivable	-136K	692K	-667K	221K	288K
Change in Other Net Operating Assets	-19.55M	1.47M	4.44M	11.75M	-6.1M
Cash from Operations	-60.21M	-37.96M	-77.59M	-102M	-116M
Capital Expenditure	-73K	-	-	-	-
Cash Acquisitions	-	118K	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Cash from Investing	-73K	118K	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-425K	-746K	-1.31M	-1.17M	-668K
Total Debt Repaid	-425K	-746K	-1.31M	-1.17M	-668K
Issuance of Common Stock	122M	76.54M	182M	120M	-
Other Financing Activities, Total	-21.51M	-1.74M	-4.5M	-6.23M	-111K
Cash from Financing	100M	74.05M	176M	113M	-779K
Foreign Exchange Rate Adjustments	-	-	-148K	1.94M	-443K
Miscellaneous Cash Flow Adjustments	-	-	-	-1K	-
Net Change in Cash	40.01M	36.2M	98.56M	12.4M	-117M
Supplemental Items
Cash Interest Paid	872K	6K	1K	1K	5K
Levered Free Cash Flow	-52.24M	-22.87M	-46.46M	-58.41M	-74.53M
Unlevered Free Cash Flow	-51.7M	-22.86M	-46.46M	-58.41M	-74.53M
Change In Net Working Capital	25.23M	-2.15M	-3.77M	-11.97M	5.99M
Net Debt Issued / Repaid	-425K	-746K	-1.31M	-1.17M	-668K

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-60.84	-32.49	-36.07	-36.14	-49.91
Return on Total Capital	-110.99	-38	-39.77	-40.22	-58.85
Return On Equity %	-181.77	-60.89	-64.22	-63.91	-92.85
Return on Common Equity	-181.77	-60.89	-64.22	-63.91	-92.85
Margin Analysis
Gross Profit Margin %	-	-	-	-	-
SG&A Margin	-	-	-	-	-
EBITDA Margin %	-	-	-	-	-
EBITA Margin %	-	-	-	-	-
EBIT Margin %	-	-	-	-	-
Income From Continuing Operations Margin %	-	-	-	-	-
Net Income Margin %	-	-	-	-	-
Net Avail. For Common Margin %	-	-	-	-	-
Normalized Net Income Margin	-	-	-	-	-
Levered Free Cash Flow Margin	-	-	-	-	-
Unlevered Free Cash Flow Margin	-	-	-	-	-
Asset Turnover
Asset Turnover	-	-	-	-	-
Fixed Assets Turnover	-	-	-	-	-
Receivables Turnover (Average Receivables)	-	-	-	-	-
Short Term Liquidity
Current Ratio	10.55	14.02	17.4	8.93	5.13
Quick Ratio	10.45	13.96	17.32	8.9	5.08
Operating Cash Flow to Current Liabilities	-11.36	-5.84	-7.09	-4.5	-6.99
Days Sales Outstanding (Average Receivables)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	0.36	-	-	-	-
Total Debt / Total Capital	0.36	-	-	-	-
LT Debt/Equity	0.03	-	-	-	-
Long-Term Debt / Total Capital	0.03	-	-	-	-
Total Liabilities / Total Assets	17.41	12.65	7.7	12.46	21.7
EBIT / Interest Expense	-50.78	-5.75K	-81.28K	-114K	-22.98K
EBITDA / Interest Expense	-49.31	-5.73K	-81.27K	-114K	-22.98K
(EBITDA - Capex) / Interest Expense	-49.4	-5.73K	-81.27K	-114K	-22.98K
Total Debt / EBITDA	-0	-	-	-	-
Net Debt / EBITDA	1.25	2.24	2.32	1.77	0.73
Total Debt / (EBITDA - Capex)	-0	-	-	-	-
Net Debt / (EBITDA - Capex)	1.25	2.24	2.32	1.77	0.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	-
Gross Profit, 1 Yr. Growth %	-	-	-	-	-
EBITDA, 1 Yr. Growth %	-40.34	-7.33	101.87	39.8	1.14
EBITA, 1 Yr. Growth %	-40.22	-7.58	101.1	39.79	1.14
EBIT, 1 Yr. Growth %	-48.54	-9.05	101.1	39.79	1.14
Earnings From Cont. Operations, 1 Yr. Growth %	-47.92	-10.79	103.63	37.56	0.43
Net Income, 1 Yr. Growth %	-47.92	-10.79	103.63	37.56	0.43
Normalized Net Income, 1 Yr. Growth %	-47.92	-10.79	103.63	37.56	0.43
Diluted EPS Before Extra, 1 Yr. Growth %	-90.95	-45.39	51.36	-12.91	-29.66
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	22.57	-91.47	-34.09	-48.28	-
Total Assets, 1 Yr. Growth %	133.59	43.17	108.76	6.39	-57.93
Tangible Book Value, 1 Yr. Growth %	-422.02	75.91	120.59	0.9	-62.37
Common Equity, 1 Yr. Growth %	-1.89K	51.43	120.59	0.9	-62.37
Cash From Operations, 1 Yr. Growth %	3	-36.95	104.39	31.64	13.62
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	303.63	-56.22	102.38	25.72	27.59
Unlevered Free Cash Flow, 1 Yr. Growth %	312.47	-55.77	102.42	25.72	27.59
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	-
Gross Profit, 2 Yr. CAGR %	-	-	-	-	-
EBITDA, 2 Yr. CAGR %	-19.01	-25.65	37.01	67.99	18.91
EBITA, 2 Yr. CAGR %	-18.72	-25.67	36.57	67.67	18.91
EBIT, 2 Yr. CAGR %	-18.99	-31.59	35.48	67.67	18.91
Earnings From Cont. Operations, 2 Yr. CAGR %	-18.3	-31.84	34.78	67.36	17.54
Net Income, 2 Yr. CAGR %	-18.3	-31.84	34.78	67.36	17.54
Normalized Net Income, 2 Yr. CAGR %	-18.3	-31.84	34.78	67.36	17.54
Diluted EPS Before Extra, 2 Yr. CAGR %	-79.64	-77.77	-9.08	14.81	-21.73
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-17.38	-67.67	-76.29	-41.61	-
Total Assets, 2 Yr. CAGR %	20.82	82.88	72.89	49.03	-33.1
Tangible Book Value, 2 Yr. CAGR %	142.8	138.01	96.99	49.19	-38.38
Common Equity, 2 Yr. CAGR %	28.31	420.7	82.76	49.19	-38.38
Cash From Operations, 2 Yr. CAGR %	-4.5	-19.42	13.52	64.03	22.3
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-